Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Merck
Johnson and Johnson
Accenture
Harvard Business School
Cerilliant
McKesson
US Department of Justice

Generated: May 20, 2018

DrugPatentWatch Database Preview

Diphenylpyraline hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for diphenylpyraline hydrochloride and what is the scope of diphenylpyraline hydrochloride patent protection?

Diphenylpyraline hydrochloride
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for diphenylpyraline hydrochloride.
Summary for diphenylpyraline hydrochloride
Synonyms for diphenylpyraline hydrochloride
1-Methyl-4-piperidyl benzhydryl ether hydrochloride
1-Methylpiperidyl-4-benzhydrylether hydrochloride
132-18-3
147-20-6 (Parent)
2169AH
4-(Benzhydryloxy)-1-methylpiperidine hydrochloride
4-(Diphenylmethoxy)-1-methylpiperidine hydrochloride
4-(diphenylmethoxy)-1-methylpiperidine, chloride
4-benzhydryloxy-1-methyl piperidine hcl
4-BENZHYDRYLOXY-1-METHYL PIPERIDINE HYDROCHLORIDE
4-benzhydryloxy-1-methyl-piperidine hydrochloride
4-BENZHYDRYLOXY-1-METHYLPIPERIDINE HCl
4-benzhydryloxy-1-methylpiperidine hydrochloride
4-benzhydryloxy-1-methylpiperidine;hydrochloride
4-benzhydryloxy-1-methylpiperidine~diphenylpyraline hydrochloride
4-DIPHENYLMETHOXY-1-METHYLPIPERIDINE
4-Diphenylmethoxy-1-methylpiperidine HCl
4-diphenylmethoxy-1-methylpiperidine hydrochlorid
4-Diphenylmethoxy-1-methylpiperidine hydrochloride
4-DIPHENYLMETHOXY-1-METHYLPIPERIDINE HYDROCHLORIDE MONOHYDRATE
4-Diphenylmethoxy-1-methylpiperidine hydrochloride, 95%
AC-9856
AC1L24JH
Aerogastol
AK-57808
AKOS022180771
Allerzine
AN-43686
Anginosan
Belfene hydrochloride
C-49657
C19H23NO.ClH
C19H23NO.HCl
CAS-132-18-3
CCG-40200
CHEBI:31508
CHEMBL1564
CS-4455
CTK8G8103
D01172
DB-042095
Diafen (antihistamine)
Diafen hydrochloride
Diafen, antihistamine
Diaphen
Diphenpyraline hydrochloride
Diphenylpyraline (hydrochloride)
Diphenylpyraline HCl
Diphenylpyraline hydrochloride (JAN)
Diphenylpyraline hydrochloride [JAN]
Diphenylpyraline Hydrochloride 1.0 mg/ml in Methanol (as free base)
DSSTox_CID_27752
DSSTox_GSID_47772
DSSTox_RID_82529
DTXSID7047772
EINECS 205-049-3
FT-0625284
G9FU7F1E87
HE198561
Hispril (TN)
Hispril hydrochloride
Histalert
HMS1570M15
HMS1920I08
HY-B0970
J-006136
KB-191247
labotest-bb lt00159897
Lergoban
LS-115275
MFCD00012835
MLS000069803
MLS001148620
MLS002222284
MolPort-003-666-168
NCGC00016395-01
NCGC00016395-06
NCGC00094658-01
NCGC00094658-02
NSC 61825
NSC-61825
NSC-756730
NSC61825
NSC756730
Opera_ID_182
P 253
Pharmakon1600-01500258
Piperidine, 4-(diphenylmethoxy)-1-methyl-, hydrochloride
Piperidine, 4-(diphenylmethoxy)-1-methyl-, hydrochloride (1:1)
Piperidine, 4-diphenylmethoxy-1-methyl-, hydrochloride
Prestwick_969
SCHEMBL212198
SMR000059141
SPECTRUM1500258
ST50319968
Sumadil
Tox21_110419
Tox21_110419_1
UNII-G9FU7F1E87
VU0244457-6

US Patents and Regulatory Information for diphenylpyraline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline HISPRIL diphenylpyraline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 011945-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
UBS
Harvard Business School
Cerilliant
Daiichi Sankyo
Johnson and Johnson
Chubb
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.